Xencor (XNCR) Treasury Shares (2018 - 2026)
Xencor (XNCR) posted quarterly Treasury Shares of $2.4 million for Q1 2026, up 786.55% year-over-year from $269246.0 in Q1 2025, and up 20.47% quarter-over-quarter from $2.0 million in Q4 2025.
Xencor (XNCR) Treasury Shares (2018 - 2026) Analysis & Trends
Xencor (XNCR) has reported Treasury Shares for 9 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 786.55% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (up 786.55% YoY), while the FY2025 annual figure was $2.0 million, up 11.07% from the prior year.
- Treasury Shares grew to $2.4 million in Q1 2026 per XNCR's latest filing, from $2.0 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.4 million in Q1 2026 and bottomed at $269246.0 in Q1 2025.
- Historically, Treasury Shares has averaged $1.6 million across 5 years, with a median of $1.7 million in 2023.
- Annual changes were most pronounced in 2025 — Treasury Shares plunged 84.27% — and 2026, when it soared 786.55%.
- Xencor's Treasury Shares stood at $1.2 million in 2022, then gained by 20.89% to $1.5 million in 2023, then climbed by 19.71% to $1.8 million in 2024, then increased by 11.07% to $2.0 million in 2025, then grew by 20.47% to $2.4 million in 2026.
- Business Quant data shows XNCR's Treasury Shares at $2.4 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Xencor | 1.73 Bn | 1.36 Bn | - | 2.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.32 Mn |
| Jun 30, 2026 | 2.32 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 269,246.00 |
| Mar 31, 2025 | 269,246.00 |
| Dec 31, 2024 | 1.78 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.71 Mn |